Newamsterdam Pharma Company N V Revenue per Employee (NAMS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Newamsterdam Pharma Company N v   (NASDAQ: NAMS)
 

Newamsterdam Pharma N V 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Newamsterdam Pharma N V 's Revenue per employee fell on a trailing twelve month basis to $ 259,370, below the company average number of $348,773.
Within the Healthcare sector Employees of 376 other companies have achieved higher revenue per employee. While Newamsterdam Pharma N V 's total ranking has deteriorated compared to the previous quarter from 1813 to 2909. Newamsterdam Pharma N V has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NAMS Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 5406.9 % -80.67 % 2.08 % -99.75 % -98.8 %
Sales per Employee (TTM) $ 259,370 71,210 225,650 225,030 352,430
NAMS's Total Ranking # 2909 # 1813 # 2161 # 1028 #
Seq. Revenue Change 417.81 % 21.74 % 9400 % -90.8 % -98.18 %

NAMS Company Profile >> Back to NAMS Efficiency Comparisons >> Compare NAMS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 147
Healthcare Sector # 377
Overall Market # 2909

Revenue per Employee Statistics
High Average Low
$ 640,060 $ 348,773 $ 71,210
(Jun 30 2025)   (Jun 30 2026)



Financial Statements
Newamsterdam Pharma N V 's Revenue MRQ $ 19 Millions Visit NAMS's Income Statement
Newamsterdam Pharma N V 's Revenues TTM $ 26 Millions Visit NAMS's aggregate revenue growth
What are NAMS's Sales? Visit NAMS's Sales by Segment




Other Ratios
Newamsterdam Pharma N V 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NAMS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NAMS's Competitors
Revenue per Employee for NAMS's Suppliers
Revenue per Employee for NAMS's Customers

You may also want to know
NAMS's Sales Growth Rates NAMS's Pe Price to earnings ratio NAMS's Receivables Turnover Ratio NAMS's Stock Quote
NAMS's Net Income Growth Rates NAMS's Ps Price to Sales ratio NAMS's Sales per Employee NAMS's Asset Turnover Ratio
NAMS's Net Margin NAMS's Pb Price to Book ratio NAMS's Financial Strength Ratios NAMS's Dividend Payout Ratio
Date modified: 2026-11-06T13:06:17+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Adc Therapeutics Sa  439,756.48 $ 84.873  Million 193 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
Abbott Laboratories  419,382.61 $ 48,229.000  Million 115,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Regenxbio Inc   414,854.45 $ 153.911  Million 371 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 
Lemaitre Vascular Inc   412,119.08 $ 269.938  Million 655 
Sotera Health Company  410,083.33 $ 1,230.250  Million 3,000 
Cryo cell International Inc   409,559.89 $ 31.127  Million 76 
Innovage Holding Corp   407,343.60 $ 1,018.359  Million 2,500 
Brightspring Health Services Inc   403,367.83 $ 9,479.144  Million 23,500 
Repligen Corp  402,805.00 $ 805.610  Million 2,000 
Lensar Inc   400,526.67 $ 60.079  Million 150 
Strata Critical Medical Inc   393,386.02 $ 236.425  Million 601 
Precipio inc   391,014.08 $ 27.762  Million 71 
Iovance Biotherapeutics inc   388,700.51 $ 378.983  Million 975 
Pro dex Inc   386,300.97 $ 79.578  Million 206 
Edap Tms Sa  385,363.32 $ 111.370  Million 289 
Msa Safety Inc  380,326.42 $ 2,015.730  Million 5,300 
Electromed Inc   378,482.23 $ 74.561  Million 197 
Maxcyte inc   377,736.26 $ 34.374  Million 91 
Amneal Pharmaceuticals Inc   376,021.65 $ 3,196.184  Million 8,500 
Mimedx Group Inc   375,449.26 $ 303.363  Million 808 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.